SCHEMBL6663218

SCHEMBL6663218

Cc1sc2ncnc(N3CCC(NC4c5ccccc5CC4O)CC3)c2c1-c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
NOD2 Q9HC29 1/20 0.52
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
STAT3 P40763 1/20 0.44
ADRB2 P07550 2/20 0.43
ADRB1 P08588 2/20 0.43
ADRB3 P13945 2/20 0.43
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FGFR1 P11362 2/20 0.39
AURKA O14965 2/20 0.39
CDC7 O00311 1/20 0.39
PLK4 O00444 1/20 0.39
CHEK1 O14757 1/20 0.39
PDPK1 O15530 1/20 0.39
JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680379 0.94 KMT2A (0.47) KMT2AMEN1NOD2ALDH1A1MAPT
SCHEMBL6700387 0.82 ADRB2 (0.55) KMT2AMEN1HTTADRB2ADRB1
SCHEMBL6663328 0.82 KMT2A (0.55) KMT2AMEN1NOD2ALDH1A1MAPT
SCHEMBL6680615 0.80 MEN1 (0.56) KMT2AMEN1ALDH1A1MAPTHTT
SCHEMBL6668006 0.77 MEN1 (0.52) KMT2AMEN1ALDH1A1MAPTHTT
SCHEMBL6666691 0.76 ADRB2 (0.48) KMT2AMEN1ADRB2ADRB1ADRB3
SCHEMBL6838303 0.76 MEN1 (0.66) KMT2AMEN1NOD2ALDH1A1MAPT
SCHEMBL6836284 0.76 KMT2A (0.56) KMT2AMEN1NOD2ALDH1A1MAPT
SCHEMBL2369149 0.74 MEN1 (0.71) KMT2AMEN1NOD2ALDH1A1MAPT
SCHEMBL6665434 0.72 MEN1 (0.53) KMT2AMEN1NOD2STAT3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138238-A1 Substituted aminopyrimidine compounds as neurokinin antagonists PREDIX PHARMACEUTICALS HOLDINGS, INC. 2004-07-15 US claimed
US-20040138238-A1 Substituted aminopyrimidine compounds as neurokinin antagonists PREDIX PHARMACEUTICALS HOLDINGS, INC. 2004-07-15 US disclosed
WO-2004014850-A2 SUBSTITUTED AMINOPYRIMIDINES AS NEUROKININ ANTAGONISTS PREDIX PHARMACEUTICALS HOLDINGS, INC. (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138238-A1 Substituted aminopyrimidine compounds as neurokinin antagonists TACR1, GRPR, BDKRB1 KMT2A 3337/4885MEN1 2034/4885NOD2 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.